Virginia Tech researcher Dr. David Kuhn is conducting a study testing the effectiveness of antibodies in warding off aquaculture disease. In this interview, Dr. Kuhn describes SIRF’s support for the project as critical, allowing for the leveraging of university funding and resources in the execution of a complete analysis.
“I think funds like SIRF are really important because they are really geared towards the industry. Helping in the near term and sustaining as well,” said Dr. Kuhn. “Without SIRF funding this project would not be taking place.”